- Home
- BFAM vs HALO Comparison
BFAM vs HALO Comparison
Compare BFAM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFAM
- HALO
- Stock Information
- Founded
- BFAM 1986
- HALO 1998
- Country
- BFAM United States
- HALO United States
- Employees
- BFAM N/A
- HALO N/A
- Industry
- BFAM Other Consumer Services
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFAM Consumer Discretionary
- HALO Health Care
- Exchange
- BFAM Nasdaq
- HALO Nasdaq
- Market Cap
- BFAM 6.9B
- HALO 7.4B
- IPO Year
- BFAM 1997
- HALO N/A
- Fundamental
- Price
- BFAM $129.16
- HALO $54.54
- Analyst Decision
- BFAM Buy
- HALO Buy
- Analyst Count
- BFAM 8
- HALO 9
- Target Price
- BFAM $139.13
- HALO $63.56
- AVG Volume (30 Days)
- BFAM 473.1K
- HALO 3.3M
- Earning Date
- BFAM 05-05-2025
- HALO 05-06-2025
- Dividend Yield
- BFAM N/A
- HALO N/A
- EPS Growth
- BFAM 93.82
- HALO 55.40
- EPS
- BFAM 2.77
- HALO 3.76
- Revenue
- BFAM $2,728,831,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- BFAM $9.64
- HALO $25.77
- Revenue Next Year
- BFAM $7.16
- HALO $18.01
- P/E Ratio
- BFAM $46.07
- HALO $14.51
- Revenue Growth
- BFAM 9.71
- HALO 25.64
- 52 Week Low
- BFAM $100.59
- HALO $42.01
- 52 Week High
- BFAM $141.90
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- BFAM 57.04
- HALO 44.48
- Support Level
- BFAM $121.33
- HALO $52.43
- Resistance Level
- BFAM $129.56
- HALO $54.26
- Average True Range (ATR)
- BFAM 3.33
- HALO 3.42
- MACD
- BFAM 0.33
- HALO -0.49
- Stochastic Oscillator
- BFAM 66.03
- HALO 30.60
About BFAM Bright Horizons Family Solutions Inc.
Bright Horizons Family Solutions Inc provides education and care solutions designed to help employers support their employees in managing their work/life balance. The company has three business segments: full-service center-based child care, backup care, and educational advisory services. The vast majority of the company's revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, tuition assistance, and education consulting. The company earns more than half of its revenue in North America.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.